ReviewBioengineering (Basel, Switzerland)2025
Voice-Based Detection of Parkinson's Disease Using Machine and Deep Learning Approaches: A Systematic Review.
Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Toward Interpretable Voice-Based Parkinson's Disease Screening via Joint Transfer Function-Feature-Classifier-Ensemble Selection.Bioengineering (Basel, Switzerland) · 2026Article
- Demographic Confounding in Voice-Based Parkinson Disease Screening: Methodological Analysis of the Bridge2AI Voice Dataset.Journal of medical Internet research · 2026Article
- A Machine Learning Approach to Voice-Based Parkinson Disease Screening Using Multiview Spectrogram and Speech Recognition Features: Diagnostic Study.JMIR medical informatics · 2026Article
- Bio-Inspired Deep Learning for Parkinson's Disease Detection: A Comparative Study Based on Vocal Biomarkers and Archimedean Spiral Analysis.Biomimetics (Basel, Switzerland) · 2026Article
- Use of machine learning and voice for multiclass classification of Parkinson's disease, chronic obstructive pulmonary disease, and healthy controls.Scientific reports · 2026Article
- Physiological classification of Parkinson's disease severity using multimodal speech biomarkers with a hybrid CNN-Mamba framework.Frontiers in physiology · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms, among which vocal impairment is one of the earliest and most prevalent. In recent years, voice analysis supported by machine learning (ML) and deep learning (DL) has emerged as a promising non-invasive method for early PD detection. We conducted a systematic review searching PubMed, Scopus, IEEE Xplore, and Web of Science databases for studies published between 2020 and September 2025. A total of 69 studies met the inclusion criteria and were analyzed in terms of dataset characteristics, speech tasks, feature extraction techniques, model architectures, validation strategies, and performance outcomes. Classical ML models such as Support Vector Machines (SVMs) and Random Forests (RFs) achieved high accuracy on small, homogeneous datasets, while DL architectures, particularly Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), and Transformer-based foundation models, demonstrated greater robustness and scalability across languages and recording conditions. Despite these advances, persistent challenges such as dataset heterogeneity, class imbalance, and inconsistent validation practices continue to hinder reproducibility and clinical translation. Overall, the field is transitioning from handcrafted feature-based pipelines toward self-supervised, representation-learning frameworks that promise improved generalizability. Future progress will depend on the development of large, multilingual, and openly accessible datasets, standardized evaluation protocols, and interpretable AI frameworks to ensure clinically reliable and equitable voice-based PD diagnostics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.